Staphylococcal pneumonia
Jump to navigation
Jump to search
Etiology
- a form of nosocomial pneumonia
- uncommon cause of community-acquired pneumonia (< 1%)[6]
- risk factors for Staphylococcal pneumonia
- diabetes mellitus
- recent history of influenza or measles
- institutionalized or hospitalized patients
- immunocompromised patients
- intravenous drug abuse
- dialysis patients
- risk factors for Staphylococcal pneumonia due to MRSA
- prior treatment for MRSA (strongest risk factor)[2]
- hospitalization or parenteral antibiotics within 90 days
- preceding influenza-like illness
- failure of conventional therapy
- injection drug use
Clinical manifestations
- exacerbation of respiratory symptoms & fever after a period of initial improvement of acute influenza symptoms
- higher fevers than were present with influenza & a cough producing purulent sputum
Radiology
- chest X-ray
- consolidation
- bronchopneumonia
- abscess with air-fluid level
- pneumatocele
- pleural-based lung nodules suggestion septic pulmonary emboli)*
- cavitary lung lesions*
* risk factors for MRSA
Complications
- septicemia
- abscess formation
- empyema
- high mortality (> CAP due to Streptococcus pneumoniae)
- prolonged hospitalization
Differential diagnosis
- Klebsiella pneumoniae
- patients with alcohol use disorder, diabetes mellitus, or severe COPD
- Mycoplasma pneumoniae
- unilateral or bilateral reticulonodular &/or patchy opacities
- no cavitary lesions
- Streptococcus pneumoniae
- although more common cause than S. aureus of post influenza pneumonia, cavitary lesions unlikely
Management
- empiric antimicrobial therapy:
- beta-lactamase-resistant penicillin 6-12 g/day IV
- nafcillin 1.0-1.5 g every 4 hours
- oxacillin 2.0 g every 4 hours
- methicillin (high incidence of interstitial nephritis)
- gentamicin may be added for 1st 48-71 hours for synergy
- vancomycin 1 g IV every 12 hours if methicillin-resistant (MRSA)
- do not use daptomycin, inactivated by pulmonary surfactant[2]
- duration of treatment:
- 3-4 weeks
- 6 weeks if septicemia
More general terms
References
- ↑ Manual of Medical Therapeutics, 28th edition, Ewald & McKenzie (eds) Little, Brown & Co, 1995, pg 301
- ↑ 2.0 2.1 2.2 Medical Knowledge Self Assessment Program (MKSAP) 11, 16, 18. American College of Physicians, Philadelphia 1998, 2012, 2018
Medical Knowledge Self Assessment Program (MKSAP) 19 Board Basics. An Enhancement to MKSAP19. American College of Physicians, Philadelphia 2022 - ↑ Mayo Internal Medicine Board Review, 1998-99, Prakash UBS (ed) Lippincott-Raven, Philadelphia, 1998, pg 796
- ↑ Harrison's Principles of Internal Medicine, 13th ed. Isselbacher et al (eds), McGraw-Hill Inc. NY, 1994, pg 615
- ↑ Geriatrics Review Syllabus, American Geriatrics Society, 5th edition, 2002-2004
- ↑ 6.0 6.1 Self WH et al. Staphylococcus aureus community-acquired pneumonia: Prevalence, clinical characteristics, and outcomes. Clin Infect Dis 2016 Aug 1; 63:300. <PubMed> PMID: https://www.ncbi.nlm.nih.gov/pubmed/27161775 <Internet> http://cid.oxfordjournals.org/content/63/3/300